Skip to main content
Erschienen in: Clinical and Translational Oncology 10/2013

01.10.2013 | Brief Research Article

Intimal–medial thickness and carotid arteries lumen in irradiated patients for head and neck cancer: preliminary data of an observational study

verfasst von: M. Faruolo, A. Fiorentino, G. Gallucci, L. Lapadula, V. Fusco

Erschienen in: Clinical and Translational Oncology | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the effect of external beam radiotherapy (EBRT) for head and neck cancer (HNC) the intimal–medial thickness (IMT) and the lumen of the carotid artery.

Methods

Patients with HNC and an indication for EBRT were enrolled. A carotid artery color Doppler examination was performed before and 6 and 12 months after EBRT.

Results

From 2008 to 2011, 50 patients were enrolled. The mean carotid IMT was 0.9 vs. 1.02 mm before and 6 months after EBRT, respectively (p = 0.0001). The common carotid artery lumen was narrowed without statistical significance, 6 months after EBRT (p = 0.3). 1 year from EBRT, the IMT increase and the lumen reduction were statistically significant (p = 0.001, p = 0.01, respectively). Neurological events (stroke or TIA) were not observed.

Conclusions

Our data showed a significant IMT increase 6 months from EBRT without a corresponding narrowing of the common carotid lumen while a significant increase 12 months after EBRT.
Literatur
1.
Zurück zum Zitat Carmody BJ, Arora S, Avena R, Curry KM, Simpkins J, Cosby K, et al. Accelerated carotid artery disease after high-dose head and neck radiotherapy: is there a role for routine carotid duplex surveillance? J Vasc Surg. 1999;30:1045–51.PubMedCrossRef Carmody BJ, Arora S, Avena R, Curry KM, Simpkins J, Cosby K, et al. Accelerated carotid artery disease after high-dose head and neck radiotherapy: is there a role for routine carotid duplex surveillance? J Vasc Surg. 1999;30:1045–51.PubMedCrossRef
2.
Zurück zum Zitat Cheng SW, Wu LL, Ting AC, Lau H, Lam LK, Wei WI. Irradiation-induced extracranial carotid stenosis in patients with head and neck malignancies. Am J Surg. 1999;178:323–8.PubMedCrossRef Cheng SW, Wu LL, Ting AC, Lau H, Lam LK, Wei WI. Irradiation-induced extracranial carotid stenosis in patients with head and neck malignancies. Am J Surg. 1999;178:323–8.PubMedCrossRef
3.
Zurück zum Zitat Cheng SWK, Ting ACW, Wu LLH. Accelerated progression of carotid stenosis in patients with previous external neck irradiation. J Vasc Surg. 2004;39:409–15.PubMedCrossRef Cheng SWK, Ting ACW, Wu LLH. Accelerated progression of carotid stenosis in patients with previous external neck irradiation. J Vasc Surg. 2004;39:409–15.PubMedCrossRef
4.
Zurück zum Zitat Chang YJ, Chang TC, Lee TC, Ryu SJ. Predictors of carotid artery stenosis after radiotherapy for head and neck cancers. J Vasc Surg. 2009;50:280–5.PubMedCrossRef Chang YJ, Chang TC, Lee TC, Ryu SJ. Predictors of carotid artery stenosis after radiotherapy for head and neck cancers. J Vasc Surg. 2009;50:280–5.PubMedCrossRef
5.
Zurück zum Zitat Cheng SWK, Ting ACW, Wu LLH. Ultrasonic analysis of plaque characteristics and intimal–medial thickness in radiation-induced atherosclerosis carotid artery. Eur J Endovasc Surg. 2002;24:499–504.CrossRef Cheng SWK, Ting ACW, Wu LLH. Ultrasonic analysis of plaque characteristics and intimal–medial thickness in radiation-induced atherosclerosis carotid artery. Eur J Endovasc Surg. 2002;24:499–504.CrossRef
6.
Zurück zum Zitat Fajardo LF. Is the pathology of radiation injury different in small vs large blood vessel? Cardiovasc Radiat Med. 1999;1:108–10.PubMedCrossRef Fajardo LF. Is the pathology of radiation injury different in small vs large blood vessel? Cardiovasc Radiat Med. 1999;1:108–10.PubMedCrossRef
7.
Zurück zum Zitat Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, et al. Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors. Theor Biol Med Model. 2012;9:37.CrossRef Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, et al. Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors. Theor Biol Med Model. 2012;9:37.CrossRef
8.
Zurück zum Zitat Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase III randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010;11:21–8.PubMedCrossRef Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase III randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010;11:21–8.PubMedCrossRef
9.
Zurück zum Zitat Dorresteijn LDA, Kappelle AC, Boogerd W, Klokman WJ, Balm AJ, Keus RB, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 2002;20:282–8.PubMedCrossRef Dorresteijn LDA, Kappelle AC, Boogerd W, Klokman WJ, Balm AJ, Keus RB, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 2002;20:282–8.PubMedCrossRef
10.
Zurück zum Zitat Li CS, Schminke U. Tan TY Extracranial carotid artery disease in nasopharyngeal carcinoma patients with post-irradiation ischemic stroke. Clin Neurol Neurosurg. 2010;112:865–8.CrossRef Li CS, Schminke U. Tan TY Extracranial carotid artery disease in nasopharyngeal carcinoma patients with post-irradiation ischemic stroke. Clin Neurol Neurosurg. 2010;112:865–8.CrossRef
11.
Zurück zum Zitat Stewart FA, Hoving S, Russel NS. Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiation Res. 2010;174:865–9.PubMedCrossRef Stewart FA, Hoving S, Russel NS. Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiation Res. 2010;174:865–9.PubMedCrossRef
12.
Zurück zum Zitat Gianicolo ME, Gianicolo EA, Tramacere F, Andrenassi MG, Portaluri M. Effects of external irradiation of the neck region on intima media thickness of the common carotid artery. Cardiovasc Ultrasound. 2010;8:8.PubMedCrossRef Gianicolo ME, Gianicolo EA, Tramacere F, Andrenassi MG, Portaluri M. Effects of external irradiation of the neck region on intima media thickness of the common carotid artery. Cardiovasc Ultrasound. 2010;8:8.PubMedCrossRef
13.
Zurück zum Zitat Nordstrom CK, Dwyer KM, Merz NB, Shircore A, Dwyer JH. Leisure time physical activity and early atherosclerosis: the Los Angeles atherosclerosis study. Am J Med. 2003;115:19–25.PubMedCrossRef Nordstrom CK, Dwyer KM, Merz NB, Shircore A, Dwyer JH. Leisure time physical activity and early atherosclerosis: the Los Angeles atherosclerosis study. Am J Med. 2003;115:19–25.PubMedCrossRef
14.
Zurück zum Zitat Muzzafar K, Collins SL, Labropoulos N, Baker WH. A prospective study of the effects of irradiation on the carotid artery. Laryngoscope. 2000;111:1811–4.CrossRef Muzzafar K, Collins SL, Labropoulos N, Baker WH. A prospective study of the effects of irradiation on the carotid artery. Laryngoscope. 2000;111:1811–4.CrossRef
15.
Zurück zum Zitat O’leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14–22.PubMedCrossRef O’leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14–22.PubMedCrossRef
16.
Zurück zum Zitat Elerding SC, Fernandez RN, Grotta JC, Lindberg RD, Causay LC, McMurtrey MJ. Carotid artery disease following external cervical irradiation. Ann Surg. 1981;194:609–15.PubMedCrossRef Elerding SC, Fernandez RN, Grotta JC, Lindberg RD, Causay LC, McMurtrey MJ. Carotid artery disease following external cervical irradiation. Ann Surg. 1981;194:609–15.PubMedCrossRef
17.
Zurück zum Zitat Cheng SW, Ting AC, Lam LK, Wei WI. Carotid stenosis after radiotherapy for nasopharyngeal carcinoma. Act Otolaryngol Head Neck Surg. 2000;126:517–21.CrossRef Cheng SW, Ting AC, Lam LK, Wei WI. Carotid stenosis after radiotherapy for nasopharyngeal carcinoma. Act Otolaryngol Head Neck Surg. 2000;126:517–21.CrossRef
18.
Zurück zum Zitat Lam WW, Leung SF, So NM, Wong KS, Liu KH, Ku PK, et al. Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy. Cancer. 2001;92:2357–63.PubMedCrossRef Lam WW, Leung SF, So NM, Wong KS, Liu KH, Ku PK, et al. Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy. Cancer. 2001;92:2357–63.PubMedCrossRef
19.
Zurück zum Zitat Fiorentino A, Cozzolino M, Caivano R, Pedicini P, Chiumento C, Oliviero C, et al. Cone-beam computed tomography dose monitoring during intensity-modulated radiotherapy in head and neck cancer: parotid glands. Clin Transl Oncol. 2012;. doi:10.1007/s1209401209464.PubMed Fiorentino A, Cozzolino M, Caivano R, Pedicini P, Chiumento C, Oliviero C, et al. Cone-beam computed tomography dose monitoring during intensity-modulated radiotherapy in head and neck cancer: parotid glands. Clin Transl Oncol. 2012;. doi:10.​1007/​s1209401209464.PubMed
20.
Zurück zum Zitat Fiorentino A, Caivano R, Metallo V, Chiumento C, Cozzolino M, Califano G, et al. Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer. Br J Radiol. 2012;85:1415–9.PubMedCrossRef Fiorentino A, Caivano R, Metallo V, Chiumento C, Cozzolino M, Califano G, et al. Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer. Br J Radiol. 2012;85:1415–9.PubMedCrossRef
Metadaten
Titel
Intimal–medial thickness and carotid arteries lumen in irradiated patients for head and neck cancer: preliminary data of an observational study
verfasst von
M. Faruolo
A. Fiorentino
G. Gallucci
L. Lapadula
V. Fusco
Publikationsdatum
01.10.2013
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 10/2013
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-013-1023-3

Weitere Artikel der Ausgabe 10/2013

Clinical and Translational Oncology 10/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.